Broad spectrum antiviral agent niclosamide and its therapeutic potential
The recent outbreak of coronavirus disease 2019 (COVID-19) highlights an urgent need for
therapeutics. Through a series of drug repurposing screening campaigns, niclosamide, an …
therapeutics. Through a series of drug repurposing screening campaigns, niclosamide, an …
SARS-CoV-2 antiviral therapy
The development of effective antiviral therapy for COVID-19 is critical for those awaiting
vaccination, as well as for those who do not respond robustly to vaccination. This review …
vaccination, as well as for those who do not respond robustly to vaccination. This review …
Antibiotics in the clinical pipeline in October 2019
MS Butler, DL Paterson - The Journal of antibiotics, 2020 - nature.com
The development of new and effective antibacterial drugs to treat multi-drug resistant (MDR)
bacteria, especially Gram-negative (G− ve) pathogens, is acknowledged as one of the …
bacteria, especially Gram-negative (G− ve) pathogens, is acknowledged as one of the …
Unlocking the potential of mesoporous silica nanoparticles in breast cancer treatment
Breast cancer is the most common cancer among women and is typically managed through
surgery, radiation therapy, and chemotherapy. However, chemotherapy drugs often lack …
surgery, radiation therapy, and chemotherapy. However, chemotherapy drugs often lack …
Identification of a drug binding pocket in TMEM16F calcium-activated ion channel and lipid scramblase
The dual functions of TMEM16F as Ca2+-activated ion channel and lipid scramblase raise
intriguing questions regarding their molecular basis. Intrigued by the ability of the FDA …
intriguing questions regarding their molecular basis. Intrigued by the ability of the FDA …
Prioritization of anti‐SARS‐Cov‐2 drug repurposing opportunities based on plasma and target site concentrations derived from their established human …
U Arshad, H Pertinez, H Box, L Tatham… - Clinical …, 2020 - Wiley Online Library
There is a rapidly expanding literature on the in vitro antiviral activity of drugs that may be
repurposed for therapy or chemoprophylaxis against severe acute respiratory syndrome …
repurposed for therapy or chemoprophylaxis against severe acute respiratory syndrome …
Drug repurposing for the treatment of bacterial and fungal infections
A Miró-Canturri, R Ayerbe-Algaba… - Frontiers in microbiology, 2019 - frontiersin.org
Multidrug-resistant (MDR) pathogens pose a well-recognized global health threat that
demands effective solutions; the situation is deemed a global priority by the World Health …
demands effective solutions; the situation is deemed a global priority by the World Health …
[HTML][HTML] Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights into current COVID‑19 therapies
GM Nitulescu, H Paunescu… - International …, 2020 - spandidos-publications.com
The major impact produced by the severe acute respiratory syndrome coronavirus 2 (SARS‑
CoV‑2) focused many researchers attention to find treatments that can suppress …
CoV‑2) focused many researchers attention to find treatments that can suppress …
Calixarenes: Generalities and their role in improving the solubility, biocompatibility, stability, bioavailability, detection, and transport of biomolecules
ES Español, MM Villamil - Biomolecules, 2019 - mdpi.com
The properties and characteristics of calix [n] arenes are described, as well as their capacity
to form amphiphilic assemblies by means of the design of synthetic macrocycles with a …
to form amphiphilic assemblies by means of the design of synthetic macrocycles with a …
Efficacy of niclosamide vs placebo in SARS-CoV-2 respiratory viral clearance, viral shedding, and duration of symptoms among patients with mild to moderate COVID …
DM Cairns, D Dulko, JK Griffiths, Y Golan… - JAMA network …, 2022 - jamanetwork.com
Importance Oral anthelmintic niclosamide has potent in vitro antiviral activity against SARS-
CoV-2. Repurposed niclosamide could be a safe and efficacious COVID-19 therapy …
CoV-2. Repurposed niclosamide could be a safe and efficacious COVID-19 therapy …